A
Albert L. Waldo
Researcher at University Hospitals of Cleveland
Publications - 237
Citations - 27748
Albert L. Waldo is an academic researcher from University Hospitals of Cleveland. The author has contributed to research in topics: Atrial fibrillation & Atrial flutter. The author has an hindex of 63, co-authored 234 publications receiving 25962 citations. Previous affiliations of Albert L. Waldo include Case Western Reserve University & University of Alabama at Birmingham.
Papers
More filters
Journal ArticleDOI
Edoxaban versus warfarin in patients with atrial fibrillation
Robert P. Giugliano,Christian T. Ruff,Eugene Braunwald,Sabina A. Murphy,Stephen D. Wiviott,Jonathan L. Halperin,Albert L. Waldo,Michael D. Ezekowitz,Jeffrey I. Weitz,Witold Rużyłło,Mikhail Ruda,Yukihiro Koretsune,Joshua Betcher,Minggao Shi,Laura T. Grip,Laura T. Grip,Shirali P. Patel,Indravadan Patel,James J. Hanyok,Michele Mercuri,Elliott M. Antman,Elliott M. Antman,Abstr Act,Abstr Act +23 more
TL;DR: Both once-daily regimens of edoxaban were noninferior to warfarin with respect to the prevention of stroke or systemic embolism and were associated with significantly lower rates of bleeding and death from cardiovascular causes.
Journal ArticleDOI
A comparison of rate control and rhythm control in patients with atrial fibrillation.
D. G. Wyse,Albert L. Waldo,John P. DiMarco,Michael J. Domanski,Yves Rosenberg,Eleanor Schron,Joyce C Kellen,H L Greene,M C Mickel,J E Dalquist,Scott D. Corley +10 more
TL;DR: Management of atrial fibrillation with the rhythm-control strategy offers no survival advantage over the rate- control strategy, and there are potential advantages, such as a lower risk of adverse drug effects, with the rate -control strategy.
Journal ArticleDOI
Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia
Arthur J. Moss,W. Jackson Hall,David S. Cannom,James P. Daubert,Steven L. Higgins,Helmut U. Klein,Joseph H. Levine,Sanjeev Saksena,Albert L. Waldo,David J. Wilber,Mary W. Brown,Moonseong Heo +11 more
TL;DR: In this article, the authors studied whether prophylactic therapy with an implanted cardioverter-defibrillator, as compared with conventional medical therapy, would improve survival in this high-risk group of patients.
Journal ArticleDOI
Rhythm control versus rate control for atrial fibrillation and heart failure
Denis Roy,Mario Talajic,Stanley Nattel,D. George Wyse,Paul Dorian,Kerry L. Lee,Martial G. Bourassa,J. Malcolm,O. Arnold,Alfred E. Buxton,A. John Camm,Stuart J. Connolly,Marc Dubuc,Anique Ducharme,Peter G. Guerra,Stefan H. Hohnloser,Jean Lambert,Jean-Yves Le Heuzey,Ole Pedersen,Jean-Lucien Rouleau,Bramah N. Singh,Lynne W. Stevenson,William G. Stevenson,Bernard Thibault,Albert L. Waldo +24 more
TL;DR: In patients with atrial fibrillation and congestive heart failure, a routine strategy of rhythm control does not reduce the rate of death from cardiovascular causes, as compared with a rate-control strategy.
Journal ArticleDOI
Effect of d-sotalol on mortality in patients with left ventricular dysfunction after recent and remote myocardial infarction
Albert L. Waldo,A. John Camm,Hans deRuyter,Peter L. Friedman,Daniel J. MacNeil,John F Pauls,Bertram Pitt,Craig M. Pratt,Peter J. Schwartz,Enrico P Veltri +9 more
TL;DR: The prophylactic use of a specific potassium-channel blocker does not reduce mortality, and may be associated with increased mortality in high-risk patients after myocardial infarction.